Fortune » - Fortune

Roche, Zealand Pharma in $5.3 billion pact for obesity drugs

Roche Holding licensed a new weight-loss drug from Zealand Pharma, bolstering the drugmaker’s effort to get into a hot market dominated by Novo Nordisk and Eli Lilly & Co.

Mar 12, 2025 - 12:38
 0
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
Roche Holding licensed a new weight-loss drug from Zealand Pharma, bolstering the drugmaker’s effort to get into a hot market dominated by Novo Nordisk and Eli Lilly & Co. Read More
Read More

Tags:

Previous Article

Exclusive: Causal Labs emerges from stealth, raises $5.5 million for AI weather ...

Next Article

We’re in Our 50s With Over $3 Million Saved Up and Want to Retire Next Year. Wha...

Related Posts

Like Meghan Markle, 80% of women take their husband’s name after marriage. But experts warn it’s a big gamble

Like Meghan Markle, 80% of women take their husband’s n...

Mar 6, 2025  0

Ford disputes analyst claim its F-150 is no longer America’s best-selling vehicle

Ford disputes analyst claim its F-150 is no longer Amer...

Feb 13, 2025  0

Netflix cooked up a new live experience for customers: A Las Vegas restaurant serving ‘Squid Game’ cocktails and a ‘Bridgerton’ tea

Netflix cooked up a new live experience for customers: ...

Feb 13, 2025  0